跳至主要内容
临床试验/DRKS00032390
DRKS00032390招募中不适用

Abscopal effects in metastasized cancer patients treated with radiotherapy and immune checkpoint inhibition - ARTIC

niversitätsklinikum Köln0 个研究点目标入组 62 人开始时间: 2023年7月31日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with documented evidence of metastatic solid tumor of any entity and simultaneous RT-ICI between 06/2015 (start ICI) and 06/2021 (end RT) at participating centers.
  • - At least one lesion outside the irradiation field: non-irradiated lesion (outside the 10% isodose, NIL)
  • - Radiological images of the NILs prior to initiation of RT (at least two) and after the end of RT (at least one) to exclude an effect induced by ICI only

排除标准

  • - Start of another systemic therapy during the time period being analyzed
  • - Inadequate imaging to assess abscopal effect or exclude response induced by ICI only

研究者

发起方
niversitätsklinikum Köln

相似试验